Contents

Clinical Cancer Drugs, Volume 2 - Number 1


Editorial


Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

, 2(1): 4 - 15

Mizue Terai and Takami Sato


DOI: 10.2174/2212697X02666150203212041



Recent Clinical Advances in the Treatment of Cutaneous Melanoma

, 2(1): 16 - 28

Martin Greco, Maximiliano Mestroni, Maximo de la Vega, Gonzalo Recondo, Matias E. Valsecchi, Gonzalo Recondo and Enrique Diaz Canton


DOI: 10.2174/2212697X02666150203212708



Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma

, 2(1): 38 - 43

Maximo de la Vega, Matias E. Valsecchi, Martin Greco, Gonzalo Recondo, Gonzalo Recondo and Enrique Diaz Canton


DOI: 10.2174/2212697X02666150203212942


Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

, 2(1): 44 - 53

Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri


DOI: 10.2174/2212697X02666150128003659



Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

, 2(1): 54 - 60

Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukozu, Daigo Matsui, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino


DOI: 10.2174/2212697X02666150313003755



Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

, 2(1): 61 - 70

Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger


DOI: 10.2174/2212697X02666150331202809




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science